BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10553262)

  • 21. Pulmonary complications following bone marrow transplantation.
    Chan CK; Hyland RH; Hutcheon MA
    Clin Chest Med; 1990 Jun; 11(2):323-32. PubMed ID: 2189666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infections in bone marrow transplant recipients.
    Sable CA; Donowitz GR
    Clin Infect Dis; 1994 Mar; 18(3):273-81; quiz 282-4. PubMed ID: 8011804
    [No Abstract]   [Full Text] [Related]  

  • 23. [Infections in bone marrow transplantation].
    Villasís-Keever A; Mosqueda JL
    Rev Invest Clin; 2005; 57(2):381-6. PubMed ID: 16524081
    [No Abstract]   [Full Text] [Related]  

  • 24. [Infections following bone marrow transplantation].
    Ljungman P; Andersson J; Sparrelid E
    Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.
    Morrison VA; Haake RJ; Weisdorf DJ
    Am J Med; 1994 Jun; 96(6):497-503. PubMed ID: 8017446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
    Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
    Transplantation; 1999 Nov; 68(10):1486-91. PubMed ID: 10589944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious complications following T-cell depleted hematopoietic stem-cell transplantation.
    Novitzky N; Rouskova A
    Cytotherapy; 2001; 3(3):165-73. PubMed ID: 12171723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectious complications in renal transplant recipients.
    Tanphaichitr NT; Brennan DC
    Adv Ren Replace Ther; 2000 Apr; 7(2):131-46. PubMed ID: 10782731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infectious complications in bone marrow transplantation].
    Gómez Casares MT; Alsar MJ; Conde E; Muruzabal MJ; Pérez Encinas M; Baro J; Iriondo A; Richard C; Garijo J; Aguado JM
    Med Clin (Barc); 1991 Mar; 96(11):405-9. PubMed ID: 2046427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical reappraisal of gastrointestinal complications of allogeneic bone marrow transplantation.
    Schiller GJ; Gale RP
    Cell Transplant; 1992; 1(2-3):265-9. PubMed ID: 1344298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infections in solid organ transplant recipients].
    Cuellar-Rodríguez J; Sierra-Madero JG
    Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation.
    Domenech J; Roingeard F; Binet C
    Leuk Lymphoma; 1997 Jan; 24(3-4):239-56. PubMed ID: 9156654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis in blood and marrow transplant recipients.
    Yuen KY; Woo PC
    Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of infection in bone marrow transplant recipients.
    Young LS
    Clin Haematol; 1984 Oct; 13(3):661-78. PubMed ID: 6388936
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation.
    Mohite U; Das M; Saikia T; Parikh P; Gopal R; Kelkar R; Advani S
    Leuk Lymphoma; 2001 Feb; 40(5-6):675-8. PubMed ID: 11426541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infections among allogeneic bone marrow transplant recipients in India.
    George B; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2004 Feb; 33(3):311-5. PubMed ID: 14647246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
    O'Donnell MR; Schmidt GM; Tegtmeier BR; Faucett C; Fahey JL; Ito J; Nademanee A; Niland J; Parker P; Smith EP
    J Clin Oncol; 1994 Apr; 12(4):827-34. PubMed ID: 8151325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants.
    Humar A; Wood S; Lipton J; Messner H; Meharchand J; McGeer A; MacDonald K; Mazzulli T
    Clin Infect Dis; 1998 Mar; 26(3):606-10. PubMed ID: 9524831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
    Hahn T; Alam AR; Lawrence D; Ford L; Baer MR; Bambach B; Bernstein ZP; Czuczman MS; Silva J; Slack JL; Wetzler M; Becker J; McCarthy PL
    Transplantation; 2004 Nov; 78(10):1515-22. PubMed ID: 15599317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspergillus infections in bone marrow transplant recipients.
    Wingard JR; Beals SU; Santos GW; Merz WG; Saral R
    Bone Marrow Transplant; 1987 Aug; 2(2):175-81. PubMed ID: 3332165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.